Market Summary
USD110.87-0.03
Delayedas of 03 Oct 2023, 01:12 pm-0.03%
A Stock Price
A RSI Chart
A Valuation
A Price/Sales (Trailing)
A Profitability
A Fundamentals
A Revenue
A Earnings
Price Action
52 Week Range
109.00159.59
(Low)(High)
Last 7 days
-0.9%
Last 30 days
-9.0%
Last 90 days
-7.1%
Trailing 12 Months
-8.6%
A Financial Health
A Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for A
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-09-28 | Gonsalves Rodney | bought | 287 | 111 | 2.59 | v.p., corporate controller |
2023-09-11 | Binns Philip | acquired | 249,159 | 113 | 2,203 | senior vice president |
2023-08-23 | Gonsalves Rodney | sold | -415,716 | 118 | -3,500 | v.p., corporate controller |
2023-08-14 | Baker Jeffery C | bought | 3,792 | 18.96 | 200 | - |
2023-07-27 | McMullen Michael R. | sold | -122,720 | 130 | -944 | ceo and president |
2023-07-27 | McMullen Michael R. | acquired | 39,761 | 42.12 | 944 | ceo and president |
2023-05-19 | MCDONNELL PADRAIG | sold (taxes) | -22,036 | 128 | -171 | sr. vice president |
2023-05-03 | Ancher-Jensen Henrik | sold (taxes) | -17,789 | 134 | -132 | sr. vice president |
2023-03-16 | SCANGOS GEORGE A | acquired | 226,848 | 136 | 1,658 | - |
2023-03-16 | Bishop Hans Edgar | acquired | 328,231 | 136 | 2,399 | - |
Which funds bought or sold A recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | unchanged | - | -2,224 | 14,969 | -% |
2023-09-20 | BARCLAYS PLC | added | 93.37 | 26,248,000 | 64,798,000 | 0.04% |
2023-09-19 | BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL | unchanged | - | -95,334 | 633,718 | 0.26% |
2023-09-13 | CGC Financial Services, LLC | new | - | 47,619 | 47,619 | 0.03% |
2023-09-12 | Farther Finance Advisors, LLC | added | 25.59 | 5,898 | 70,226 | 0.01% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 37,398 | 37,398 | -% |
2023-08-29 | Garde Capital, Inc. | unchanged | - | -240,000 | 1,597,000 | 0.13% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | -8,160 | 73,488 | 0.01% |
2023-08-25 | Gould Capital, LLC | unchanged | - | -2,406 | 15,993 | 0.01% |
2023-08-25 | Brown Shipley& Co Ltd | added | 14.74 | -7,563 | 2,858,700 | 1.17% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of Agilent Tech
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | price t rowe associates inc /md/ | 2.6% | 7,707,066 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 8.53% | 25,250,988 | SC 13G/A | |
| Jan 26, 2023 | blackrock inc. | 10.9% | 32,309,878 | SC 13G/A | |
| Jan 20, 2023 | blackrock inc. | 10.9% | 32,309,878 | SC 13G/A | |
| Apr 08, 2022 | blackrock inc. | 10.0% | 30,082,335 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 7.1% | 21,689,105 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 8.04% | 24,269,735 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 9.7% | 29,352,219 | SC 13G/A | |
| Feb 16, 2021 | price t rowe associates inc /md/ | 7.6% | 23,512,823 | SC 13G/A | |
| Feb 10, 2021 | vanguard group inc | 7.76% | 23,804,938 | SC 13G/A |
Recent SEC filings of Agilent Tech
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Sep 29, 2023 | 4 | Insider Trading | |
| Sep 13, 2023 | 4 | Insider Trading | |
| Sep 13, 2023 | 3 | Insider Trading | |
| Sep 05, 2023 | 8-K | Current Report | |
| Aug 31, 2023 | 10-Q | Quarterly Report | |
| Aug 25, 2023 | 4 | Insider Trading | |
| Aug 23, 2023 | 144 | Notice of Insider Sale Intent | |
| Aug 15, 2023 | 8-K | Current Report | |
| Jul 31, 2023 | 4 | Insider Trading | |
| Jul 27, 2023 | 144 | Notice of Insider Sale Intent |
A Fair Value
Loading...
Peers (Alternatives to Agilent Tech)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
A | 32.5B | 7.0B | -9.03% | -8.60% | 28.68 | 4.65 | 5.03% | -14.68% |
MTD | 23.8B | 4.0B | -11.06% | 0.30% | 26.75 | 6.01 | 2.30% | 16.37% |
ILMN | 21.6B | 4.5B | -19.01% | -28.49% | -5.15 | 4.83 | -4.92% | -21931.58% |
PKI | 16.1B | 2.8B | -15.95% | -22.45% | 19.74 | 5.69 | -24.31% | 21.35% |
WAT | 16.0B | 3.0B | -3.74% | 0.37% | 23.68 | 5.34 | 3.16% | -3.93% |
| MID-CAP | ||||||||
| SMALL-CAP | ||||||||
PACB | 2.0B | 146.1M | -29.45% | 38.67% | -6.32 | 13.8 | 4.72% | -55.19% |
QTRX | 1.0B | 112.0M | -0.96% | 142.38% | -15.25 | 8.96 | 0.83% | 16.42% |
ADPT | 750.7M | 189.6M | -23.79% | -27.11% | -3.93 | 3.96 | 18.74% | 17.75% |
HBIO | 181.9M | 114.1M | -3.40% | 66.41% | -33.5 | 1.59 | -5.49% | -48.58% |
CDXS | 138.2M | 99.2M | 10.00% | -67.33% | -2.44 | 1.39 | -26.56% | -199.52% |
BNGO | 97.4M | 31.5M | -23.90% | 60.11% | -0.66 | 3.09 | 35.12% | -38.47% |
CSBR | 82.9M | 52.7M | -3.00% | -18.00% | -10.98 | 1.57 | 2.10% | -1984.29% |
NSTG | 72.7M | 143.9M | -40.58% | -88.02% | -0.44 | 0.51 | 0.71% | -18.99% |
PSNL | 61.1M | 67.1M | -31.89% | -57.58% | -0.55 | 0.91 | -12.13% | -17.68% |
Agilent Tech News
Returns for A
Cumulative Returns on A
12.3%
10-Year Cumulative Returns
13.8%
7-Year Cumulative Returns
9.6%
5-Year Cumulative Returns
3.9%
3-Year Cumulative Returns
Risks for A
What is the probability of a big loss on A?
47.3%
Probability that Agilent Tech stock will be more than 20% underwater in next one year
11.5%
Probability that Agilent Tech stock will be more than 30% underwater in next one year.
0%
Probability that Agilent Tech stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does A drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Agilent Tech was unfortunately bought at previous high price.
Drawdowns
Financials for Agilent Tech
Income Statement (Last 12 Months)(In Millions)
| Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
| Revenue | -0.7% | 6,994 | 7,040 | 6,930 | 6,848 | 6,659 | 6,527 | 6,445 | 6,319 | 6,142 | 5,817 | 5,530 | 5,339 | 5,223 | 5,236 | 5,236 | 5,163 | 5,090 | 5,019 | 4,987 | 4,914 | 4,809 |
| Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,184 |
| Costs and Expenses | 4.3% | 5,581 | 5,349 | 5,262 | 5,230 | 5,117 | 5,060 | 5,050 | 4,972 | 4,891 | 4,672 | 4,571 | 4,493 | 4,426 | 4,444 | 4,330 | 4,222 | 4,155 | 4,088 | 4,062 | 4,010 | 3,950 |
| S&GA Expenses | -0.3% | 1,663 | 1,668 | 1,639 | 1,637 | 1,604 | 1,595 | 1,629 | 1,619 | 1,617 | 1,561 | 1,499 | 1,496 | 1,494 | 1,513 | 1,509 | 1,460 | 1,435 | 1,410 | 1,397 | 1,389 | 1,376 |
| R&D Expenses | 0.4% | 486 | 484 | 473 | 467 | 464 | 461 | 455 | 441 | 427 | 406 | 494 | 495 | 495 | 504 | 406 | 404 | 406 | 402 | 395 | 387 | 374 |
| EBITDA | -100.0% | - | 2,021 | 1,985 | 1,905 | 1,907 | 1,843 | 1,777 | 1,762 | 1,587 | 1,470 | 1,317 | 1,228 | 1,178 | 1,158 | 1,229 | - | - | - | - | - | - |
| EBITDA Margin | -100.0% | - | 0.29* | 0.29* | 0.28* | 0.29* | 0.28* | 0.28* | 0.28* | 0.26* | 0.25* | 0.24* | 0.23* | 0.23* | 0.22* | 0.23* | - | - | - | - | - | - |
| Interest Expenses | 5.5% | 96.00 | 91.00 | 88.00 | 84.00 | 82.00 | 84.00 | 83.00 | 81.00 | 79.00 | 77.00 | 77.00 | 78.00 | 80.00 | 79.00 | 76.00 | 74.00 | 71.00 | 71.00 | 73.00 | 75.00 | 77.00 |
| Earnings Before Taxes | -16.2% | 1,374 | 1,639 | 1,595 | 1,504 | 1,497 | 1,427 | 1,367 | 1,360 | 1,195 | 1,087 | 935 | 842 | 790 | 793 | 890 | 919 | 932 | 952 | 961 | 946 | 928 |
| EBT Margin | -100.0% | - | 0.23* | 0.23* | 0.22* | 0.22* | 0.22* | 0.21* | 0.22* | 0.19* | 0.19* | 0.17* | 0.16* | 0.15* | 0.15* | 0.17* | - | - | - | - | - | - |
| Net Income | -16.1% | 1,133 | 1,351 | 1,323 | 1,254 | 1,328 | 1,263 | 1,205 | 1,210 | 990 | 925 | 810 | 719 | 691 | 683 | 764 | 1,071 | 1,072 | 1,117 | 1,140 | 316 | 298 |
| Net Income Margin | -100.0% | - | 0.19* | 0.19* | 0.18* | 0.20* | 0.19* | 0.19* | 0.19* | 0.16* | 0.16* | 0.15* | 0.13* | 0.13* | 0.13* | 0.15* | - | - | - | - | - | - |
| Free Cashflow | -100.0% | - | 1,183 | 1,061 | 1,021 | 1,022 | 1,058 | 1,280 | 1,297 | 1,268 | 1,253 | 1,092 | 802 | 736 | 666 | 599 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
| Assets | -1.1% | 10,675 | 10,792 | 10,919 | 10,532 | 10,484 | 10,455 | 10,327 | 10,705 | 10,491 | 10,398 | 9,674 | 9,627 | 9,546 | 9,455 | 9,501 | 9,452 | 8,625 | 9,022 | 8,952 | 8,558 | 8,349 |
| Current Assets | 2.1% | 4,030 | 3,949 | 4,078 | 3,778 | 3,690 | 3,643 | 3,474 | 3,799 | 3,632 | 3,514 | 3,483 | 3,415 | 3,245 | 3,171 | 3,102 | 3,189 | 3,457 | 3,812 | 3,712 | 3,848 | 3,667 |
| Cash Equivalents | 13.1% | 1,329 | 1,175 | 1,250 | 1,053 | 1,073 | 1,188 | 1,116 | 1,490 | 1,435 | 1,387 | 1,336 | 1,441 | 1,364 | 1,329 | 1,232 | 1,388 | 1,771 | 2,161 | 2,064 | 2,254 | 2,139 |
| Inventory | -2.8% | 1,072 | 1,103 | 1,111 | 1,038 | 1,010 | 937 | 879 | 830 | 818 | 791 | 755 | 720 | 746 | 750 | 706 | 679 | 660 | 657 | 653 | 638 | 623 |
| Net PPE | 2.3% | 1,211 | 1,184 | 1,147 | 1,100 | 1,054 | 1,010 | 974 | 945 | 905 | 884 | 866 | 845 | 846 | 836 | 844 | 850 | 839 | 827 | 829 | 822 | 801 |
| Goodwill | 0.1% | 3,984 | 3,980 | 3,983 | 3,952 | 3,948 | 3,956 | 3,964 | 3,975 | 3,976 | 4,054 | 3,618 | 3,602 | 3,606 | 3,582 | 3,589 | 3,593 | 3,107 | 3,112 | 3,133 | 2,973 | 2,933 |
| Liabilities | 2.1% | 5,117 | 5,011 | 5,310 | 5,227 | 5,393 | 5,333 | 5,173 | 5,316 | 5,545 | 5,588 | 4,870 | 4,754 | 4,565 | 4,687 | 4,653 | 4,704 | 3,878 | 3,897 | 3,916 | 3,961 | 3,781 |
| Current Liabilities | 5.6% | 1,760 | 1,666 | 1,936 | 1,861 | 1,902 | 1,813 | 1,584 | 1,708 | 1,724 | 1,758 | 1,687 | 1,467 | 1,314 | 1,945 | 1,892 | 2,080 | 1,622 | 1,118 | 1,095 | 1,171 | 1,014 |
| Short Term Borrowings | - | 55.00 | - | 238 | 36.00 | 180 | 175 | - | - | 130 | 205 | 314 | 75.00 | 40.00 | 700 | 675 | 616 | 504 | - | - | - | - |
| Long Term Debt | 0.0% | 2,734 | 2,733 | 2,733 | 2,733 | 2,732 | - | - | 2,729 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| LT Debt, Non Current | - | - | - | - | - | - | 2,730 | 2,730 | 2,729 | 2,728 | 2,727 | 2,185 | 2,284 | 2,283 | 1,788 | 1,787 | 1,791 | 1,294 | 1,798 | 1,798 | 1,799 | 1,799 |
| Shareholder's Equity | -3.9% | 5,558 | 5,781 | 5,609 | 5,305 | 5,091 | 5,122 | 5,154 | 5,389 | 4,946 | 4,810 | 4,804 | 4,873 | 4,981 | 4,768 | 4,848 | 4,748 | 4,747 | 5,125 | 5,036 | 4,571 | 4,568 |
| Retained Earnings | -36.6% | 444 | 700 | 541 | 324 | 139 | 160 | 159 | 348 | 90.00 | -12.00 | 4.00 | 81.00 | 130 | 15.00 | 73.00 | -18.00 | -122 | 178 | 90.00 | -336 | -416 |
| Additional Paid-In Capital | 0.4% | 5,382 | 5,360 | 5,345 | 5,325 | 5,311 | 5,292 | 5,290 | 5,320 | 5,307 | 5,271 | 5,266 | 5,311 | 5,324 | 5,288 | 5,293 | 5,277 | 5,270 | 5,343 | 5,324 | 5,308 | 5,312 |
| Shares Outstanding | -0.7% | 293 | 295 | 296 | 295 | 298 | 299 | 301 | 302 | 303 | 304 | 306 | 306 | 309 | 309 | 310 | 309 | 312 | 317 | 318 | 318 | 320 |
| Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.00 | 4.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
| Cashflow From Operations | 16.1% | 1,704 | 1,468 | 1,353 | 1,312 | 1,305 | 1,313 | 1,502 | 1,485 | 1,421 | 1,377 | 1,218 | 921 | 858 | 810 | 749 | 1,021 | 1,079 | 1,034 | 1,085 | 1,087 | 1,003 |
| Share Based Compensation | 0.8% | 123 | 122 | 125 | 125 | 121 | 115 | 114 | 110 | 108 | 105 | 96.00 | 83.00 | 78.00 | 76.00 | 75.00 | 72.00 | 71.00 | 67.00 | 63.00 | 70.00 | 68.00 |
| Cashflow From Investing | -4.4% | -380 | -364 | -363 | -338 | -287 | -275 | -786 | -749 | -717 | -688 | -154 | -147 | -1,313 | -1,332 | -1,335 | -1,590 | -511 | -933 | -928 | -705 | -650 |
| Cashflow From Financing | 3.6% | -1,070 | -1,110 | -843 | -1,372 | -1,355 | -1,215 | -926 | -696 | -641 | -650 | -972 | -717 | 49.00 | -302 | -238 | -299 | -927 | -934 | -956 | -797 | -772 |
| Dividend Payments | - | - | - | - | 250 | - | - | - | 236 | - | - | - | 222 | - | - | - | 206 | - | - | - | 191 | - |
| Buy Backs | 1.9% | 630 | 618 | 767 | 1,139 | 1,140 | 930 | 891 | 788 | 902 | 822 | 753 | 469 | 268 | 784 | 708 | 723 | 760 | 454 | 450 | 422 | 336 |
A Income Statement
2023-07-31CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Jul. 31, 2023 | Jul. 31, 2022 | Jul. 31, 2023 | Jul. 31, 2022 | |
| Net revenue: | ||||
| Net revenue | $ 1,672 | $ 1,718 | $ 5,145 | $ 4,999 |
| Costs and expenses: | ||||
| Cost of revenue | 1,014 | 779 | 2,595 | 2,289 |
| Research and development | 118 | 116 | 367 | 348 |
| Selling, general and administrative | 407 | 412 | 1,241 | 1,215 |
| Total costs and expenses | 1,539 | 1,307 | 4,203 | 3,852 |
| Income from operations | 133 | 411 | 942 | 1,147 |
| Interest income | 13 | 2 | 34 | 4 |
| Interest expense | (24) | (19) | (73) | (61) |
| Other income (expense), net | 10 | 3 | 16 | (41) |
| Income before taxes | 132 | 397 | 919 | 1,049 |
| Provision for income taxes | 21 | 68 | 154 | 163 |
| Net income | $ 111 | $ 329 | $ 765 | $ 886 |
| Net income per share | ||||
| Basic | $ 0.38 | $ 1.10 | $ 2.59 | $ 2.95 |
| Diluted | $ 0.38 | $ 1.10 | $ 2.58 | $ 2.94 |
| Weighted average shares used in computing net income per share: | ||||
| Basic | 294 | 298 | 295 | 300 |
| Diluted | 295 | 299 | 296 | 301 |
| Product | ||||
| Net revenue: | ||||
| Net revenue | $ 1,222 | $ 1,306 | $ 3,819 | $ 3,773 |
| Costs and expenses: | ||||
| Cost of revenue | 784 | 558 | 1,890 | 1,633 |
| Service and Other | ||||
| Net revenue: | ||||
| Net revenue | 450 | 412 | 1,326 | 1,226 |
| Costs and expenses: | ||||
| Cost of revenue | $ 230 | $ 221 | $ 705 | $ 656 |
A Balance Sheet
2023-07-31CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($) $ in Millions | Jul. 31, 2023 | Oct. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 1,329 | $ 1,053 |
| Accounts receivable, net | 1,339 | 1,405 |
| Inventory | 1,072 | 1,038 |
| Other current assets | 290 | 282 |
| Total current assets | 4,030 | 3,778 |
| Property, plant and equipment, net | 1,211 | 1,100 |
| Goodwill | 3,984 | 3,952 |
| Other intangible assets, net | 502 | 821 |
| Long-term investments | 190 | 195 |
| Other assets | 758 | 686 |
| Total assets | 10,675 | 10,532 |
| Current liabilities: | ||
| Accounts payable | 452 | 580 |
| Employee compensation and benefits | 331 | 455 |
| Deferred revenue | 512 | 461 |
| Short-term debt | 55 | 36 |
| Other accrued liabilities | 410 | 329 |
| Total current liabilities | 1,760 | 1,861 |
| Long-term debt | 2,734 | 2,733 |
| Retirement and post-retirement benefits | 92 | 97 |
| Other long-term liabilities | 531 | 536 |
| Total liabilities | 5,117 | 5,227 |
| Commitments and Contingencies (Note 9 and 12) | ||
| Stockholders' equity: | ||
| Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding at July 31, 2023 and October 31, 2022 | 0 | 0 |
| Common stock; $0.01 par value; 2 billion shares authorized; 293 million shares at July 31, 2023 and 295 million shares at October 31, 2022, issued and outstanding | 3 | 3 |
| Additional paid-in-capital | 5,382 | 5,325 |
| Retained earnings | 444 | 324 |
| Accumulated other comprehensive loss | (271) | (347) |
| Total stockholder's equity | 5,558 | 5,305 |
| Total liabilities and equity | $ 10,675 | $ 10,532 |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.